摘要 |
This invention relates to the provision of novel aminomethyl-substituted thiazolobenzimidazole derivatives represented by the following general formula (I) or a salt thereof. The aforementioned derivative or a salt thereof has a metabotropic glutamate receptor action and excellent oral activity and is therefore useful as a medicament. (In the formula, R<SUP>1</SUP>: an oxygen-containing saturated hetero ring or the like, Alk<SUB>1</SUB>: a lower alkylene, m: 0 or 1, Alk<SUB>2</SUB>: a lower alkylene which may be substituted with oxo group, n: 0 or 1, X: a bond, O, S or NR<SUP>5</SUP>, R<SUP>3</SUP>: H or the like, and R<SUP>2</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6 </SUP>and R<SUP>7</SUP>: the same or different from one another and each represents H or the like. Provided that R<SUP>3 </SUP>does not represent a lower alkyl or a halogeno-lower alkyl when X is a bond and n is 1. Also, R<SUP>4 </SUP>represents a group other than Me when m is 1, R<SUP>1 </SUP>is OH or OMe and Alk<SUB>1 </SUB>is a C<SUB>1-3 </SUB>alkylene, and further 1) when X is a bond, n is 1 and R<SUP>3 </SUP>is H, or 2) when X is a bond, n is 0 and R<SUP>3 </SUP>is cyclohexane.)
|